Our experienced senior management team members have held senior executive roles at multinational pharmaceutical companies and many led the development and regulatory approvals of pharmaceutical products in markets around the globe. Our research and development team members played a key role in the clinical development of numerous significant drugs, including Herceptin, Rituxan, Xeloda, Pegasys, PEG-Intron, Rebetol, IV Temodol, Requip, Suboxone, Subutex and Nothera. The leadership of our commercial team has launched more than 50 drugs and drug products in multiple markets around the world. A number of our executive officers have significant experience in corporate governance matters, public capital markets transactions, licensing and partnerships, and mergers and acquisitions. We believe this unique combination of executive skill sets has the potential to create substantial long term value for investors.

Athenex Global Harmonization meeting held June 8-10, 2018 in Buffalo, NY (USA)

Our Board of Directors

The Athenex Board of Directors is composed of carefully selected professionals who bring a wealth of governance and global corporate experience.

Learn More >>

Our Leadership Team

We have a comprehensive and experienced leadership team who have come together under one organization to achieve our mission.

Learn More >>

Other Key People

The Athenex team includes a deep bench of professionals with experience in pharmaceutical research, product development, manufacturing and quality assurance.

Learn More >>

Our Advisors

Our talented advisors assist the company on an as needed basis in activities ranging from trends in emerging scientific discoveries to best in class therapeutic treatments.

Learn More >>